These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20420014)

  • 1. [Positron emission tomography/computed tomography in patients with cancer of unknown primary origin].
    Lucić SM; Lucić MA; Peter A; Jovanović D; Vucaj-Cirilović V
    Acta Chir Iugosl; 2009; 56(4):159-64. PubMed ID: 20420014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
    Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin.
    Ambrosini V; Nanni C; Rubello D; Moretti A; Battista G; Castellucci P; Farsad M; Rampin L; Fiorentini G; Franchi R; Canini R; Fanti S
    Radiol Med; 2006 Dec; 111(8):1146-55. PubMed ID: 17171520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
    Kaya AO; Coskun U; Unlu M; Akdemir UO; Ozdemir NY; Zengin N; Benekli M; Yildiz R; Yaman E; Ozturk B; Gumus M; Uner A; Yamac D; Ucgul E; Buyukberber S
    Asian Pac J Cancer Prev; 2008; 9(4):683-6. PubMed ID: 19256759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up.
    Yapar Z; Kibar M; Yapar AF; Paydas S; Reyhan M; Kara O; Buyukdereli G; Aydin M; Kelle AP; Unal I; Disel U; Yavuz S; Sahin B; Erkisi M
    Nucl Med Commun; 2010 Jan; 31(1):59-66. PubMed ID: 19952921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of (18)F-fluorodeoxyglucose-positron emission tomography-computerized tomography in the identification of the primary tumor in patients with cancer of unknown origin].
    Talavera-Rubio Mdel P; García-Vicente AM; Palomar-Muñoz AM; Pilkington-Woll JP; Poblete-García VM; Soriano-Castrejón A
    Med Clin (Barc); 2013 Jan; 140(1):14-9. PubMed ID: 23177314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
    Hu M; Li MH; Kong L; Liu NB; Yang GR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):699-701. PubMed ID: 19173915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
    Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis.
    Chen YH; Yang XM; Li SS; Wang YH; He JJ; Yang YD; Wang S; Liu JJ; Zhang XL
    J Med Imaging Radiat Oncol; 2012 Feb; 56(1):66-74. PubMed ID: 22339748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography.
    Nassenstein K; Veit-Haibach P; Stergar H; Gutzeit A; Freudenberg L; Kuehl H; Fischer M; Barkhausen J; Bockisch A; Antoch G
    Acta Radiol; 2007 Dec; 48(10):1101-8. PubMed ID: 17963088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
    Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
    Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
    Deonarine P; Han S; Poon FW; de Wet C
    Scott Med J; 2013 Aug; 58(3):154-62. PubMed ID: 23960054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.
    Elboga U; Kervancioğlu S; Sahin E; Basibuyuk M; Celen YZ; Aktolun C
    Int J Clin Exp Pathol; 2014; 7(12):8941-6. PubMed ID: 25674269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
    Paul SA; Stoeckli SJ; von Schulthess GK; Goerres GW
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):189-95. PubMed ID: 17177026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unknown primary tumors: detection with dual-modality PET/CT--initial experience.
    Gutzeit A; Antoch G; Kühl H; Egelhof T; Fischer M; Hauth E; Goehde S; Bockisch A; Debatin J; Freudenberg L
    Radiology; 2005 Jan; 234(1):227-34. PubMed ID: 15564390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
    Lassen U; Daugaard G; Eigtved A; Damgaard K; Friberg L
    Eur J Cancer; 1999 Jul; 35(7):1076-82. PubMed ID: 10533451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
    Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L
    Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.